Imatinib Mesylate 72819-0186-03

Package NDC

72819-0186-03

Manufacturer: Archis Pharma Llc
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: September 1, 2022
Listing Expires: December 31, 2026
Application: ANDA212135

Need to source Imatinib Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Imatinib Mesylate	400 mg/1

Drug Class

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]

Selected Package

72819-0186-03Selected

30 TABLET in 1 BOTTLE (72819-186-03)